DMTX

Dimension Therapeutics, Inc
DMTX

Overview Fund Activity
Delisted

DMTX was delisted on the 6th of November, 2017.

Back to rankings

52 hedge funds and large institutions have $129M invested in Dimension Therapeutics, Inc in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+12
Holders Change %
+30%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
21
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity International
Fidelity International
Bermuda
$10.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
$2.56M
3
BFA
BlackRock Fund Advisors
California
$1.9M
4
Goldman Sachs
Goldman Sachs
New York
$580K
5
SIM
Spark Investment Management
New York
$367K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$29.4M
2
Jennison Associates
Jennison Associates
New York
$0
3
FCMI
Foresite Capital Management III
California
$0
4
PHS
PFM Health Sciences
California
$4M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$1.15M
Name Holding Trade Value Shares
Change 		Shares
Change %
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$3.04K +$3.04K +507 New
TRCT
52
Tower Research Capital (TRC)
New York
$1K +$1K +150 New
Jennison Associates
53
Jennison Associates
New York
– -$5.83M -745,801 Closed
FCMI
54
Foresite Capital Management III
California
– -$770K -98,297 Closed
Wells Fargo
55
Wells Fargo
California
– -$8K -1,020 Closed
1 2
3